¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"stem cell defect"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
hairy cell leukemia
Åм¼Æ÷¹éÇ÷º´
hemolytic plaque-forming cell
¿ëÇ÷ÆÇÇü¼º¼¼Æ÷, ¿ëÇ÷ÇöóÅ©Çü¼º¼¼Æ÷
hepatosplenic T-cell lymphoma
°£ºñÀåT¼¼Æ÷¸²ÇÁÁ¾
heteroploid cell line
À̼öü¼¼Æ÷°è
heterotrophic cell
Á¾¼Ó¿µ¾ç¼¼Æ÷
high-threshold cell
°í¹®Åΰª¼¼Æ÷
horizontal cell
¼öÆò¼¼Æ÷
horny cell
°¢Áú¼¼Æ÷
human diploid cell vaccine
»ç¶÷µÎ¹è¼ö¼¼Æ÷¹é½Å
human T-cell lymphoma/leukemic virus
»ç¶÷T¼¼Æ÷¸²ÇÁÁ¾/¹éÇ÷º´¹ÙÀÌ·¯½º
human T-cell lymphotropic virus
»ç¶÷T¼¼Æ÷¸²ÇÁģȹÙÀÌ·¯½º
Hurthle cell adenoma
ÈÖ¸£Æ²·¹¼¼Æ÷»ùÁ¾
hybrid cell
ÀâÁ¾¼¼Æ÷
islet cell
¼¶¼¼Æ÷
islet cell adenoma
¼¶¼¼Æ÷»ùÁ¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
lacunar cell
°ø°£¼¼Æ÷
large cell carcinoma
Å«¼¼Æ÷¾ÏÁ¾, ´ë¼¼Æ÷¾ÏÁ¾
lepra cell
³ªº´¼¼Æ÷
leukemic cell
¹éÇ÷º´¼¼Æ÷
light cell
¹àÀº¼¼Æ÷
lipoid cell
ÁöÁú¼¼Æ÷
luteal cell
Ȳü¼¼Æ÷
lymphoid cell
¸²ÇÁ°è¼¼Æ÷, ¸²ÇÁ¸ð¾ç¼¼Æ÷
lymphokine-activated killer cell
¸²Æ÷Ä«ÀÎȰ¼º¼¼Æ÷µ¶¼º¼¼Æ÷
lymphopoietic cell
¸²ÇÁ±¸»ý¼º¼¼Æ÷
marrow cell
°ñ¼ö¼¼Æ÷
mast cell
ºñ¸¸¼¼Æ÷
mastoid air cell
²ÀÁö¹úÁý
matrix cell
±âÁú¼¼Æ÷, ÅйÙÅÁÁú¼¼Æ÷
memory cell
¸é¿ª±â¾ï¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
hairy cell
¸ð¹ß»ó¼¼Æ÷
hairy cell leukemia
¸ð¹ß»ó¼¼Æ÷¹éÇ÷º´
hairy cell leukemia
¸ð¹ß»ó¼¼Æ÷¹éÇ÷º´, Åм¼Æ÷¹éÇ÷º´
hairy cell leukemia
Åм¼Æ÷ ¹éÇ÷º´
hairy cell leukemia
¸ð¹ß»ó¼¼Æ÷ ¹éÇ÷º´
hairy-cell leukemia
¸ð¹ß»ó¼¼Æ÷¹éÇ÷º´
heart failure cell
½ÉºÎÀü¼¼Æ÷(¡á¬øà)
helmet cell
Åõ±¸¼¼Æ÷
helper T cell
Á¶·ÂT¼¼Æ÷, º¸Á¶T¼¼Æ÷
helper T cell
º¸Á¶ T¼¼Æ÷
helper T cell
º¸Á¶ T ¼¼Æ÷
helper cell
º¸Á¶¼¼Æ÷
helper cell
Á¶·Â¼¼Æ÷, º¸Á¶¼¼Æ÷
helper cell activity
Á¶·Â¼¼Æ÷´É, º¸Á¶¼¼Æ÷´É
hematopoietic cell transplantation
Á¶Ç÷¼¼Æ÷À̽Ä(¡á¬øàì¹ãÕ)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
acinar cell
¼±¹æ¼¼Æ÷(¡á¬øà)
acinic cell carcinoma
¼±¹æ¼¼Æ÷¾ÏÁ¾(¡á¬øàäßðþ)
acinic cell tumor
¼±¹æ¼¼Æ÷Á¾(¡á¬øàðþ)
activation, polyclonal B cell
´Ù¼¼Æ÷±º B¼¼Æ÷Ȱ¼º, ¿©·¯¹«¸® B¼¼Æ÷Ȱ¼º
adamantinoid basal cell carcinoma
¹ý¶û Á¾¾ç(ÛöÕË ðþåÆ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adcc(antibody dependent cell mediated cytotoxicity)
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
adenoid basal cell carcinoma
¼±»ó(àÍßÒ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adenoid squamous cell carcinoma
¼±»ó ÆíÆò »óÇǼ¼Æ÷(àÍßÒ ø·øÁ ß¾ù«á¬øà) ¾Ï
adult T Cell leukemia virus
¼ºÀÎ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
adult T cell leukemia virus (HTLV)
¼ºÀÎT¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
adult t-cell leukemia/lymphoma
¼º¼÷ T-¼¼Æ÷ ¹éÇ÷º´/¸²ÇÁÁ¾(à÷âÙ¡á¬øà ÛÜúìÜ»/¡ðþ)
aggressive basal cell carcinoma
ħ½À ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell tumor
¾ËÆÄ ¼¼Æ÷Á¾(¡á¬øàðþ)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½